Biovector™ nanoparticles improve antinociceptive efficacy of nasal morphine

被引:50
作者
Betbeder, D
Sperandio, S
Latapie, JP
de Nadai, J
Etienne, A
Zajac, JM
Frances, B
机构
[1] Biovector Therapeut SA, F-31676 Labege, France
[2] CNRS, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France
关键词
nasal; Biovector (TM); nanoparticles; morphine; antinociception; tail-flick test; mouse;
D O I
10.1023/A:1007594602449
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. We have studied the antinociceptive activity and blood and brain delivery of nasal morphine with or without Biovector(TM) nanoparticles in mice. Methods. A tail flick assay was used to evaluate the antinociceptive activity. The kinetics of morphine were evaluated in blood and brain, using tritiated morphine as tracer. Results. These nanoparticles were shown to increase the duration of the antinociceptive activity of morphine after nasal administration. This effect was not due to an increase of morphine in the blood; and the analgesic activity of morphine in association with nanoparticles was reversed by naloxone. The ED50 value was 33.6 +/- 15.6 mg/kg for morphine alone and 14.4 +/- 7.6 mg/kg in presence of nanoparticles. They were only effective at low doses (1.5 to 2.5 mu g), a higher or a lower dose had no effect. No interaction was found between nanoparticles and morphine. NaDOC, a permeation enhancer, was unable to improve nasal morphine activity. Conclusions. These results show the presence of nanoparticles only at a very specific dose increases the antinociceptive activity of nasal morphine in mice. The occurrence of a direct transport of morphine from the nasal mucosa to the brain is discussed.
引用
收藏
页码:743 / 748
页数:6
相关论文
共 34 条
[1]   MORPHINE AND MORPHINE METABOLITE KINETICS IN THE RAT-BRAIN AS ASSESSED BY TRANSCORTICAL MICRODIALYSIS [J].
BARJAVEL, M ;
SANDOUK, P ;
PLOTKINE, M ;
SCHERRMANN, JM .
LIFE SCIENCES, 1994, 55 (16) :1301-1308
[2]   OLFACTORY NEURAL PATHWAY IN MOUSE HEPATITIS-VIRUS NASOENCEPHALITIS [J].
BARTHOLD, SW .
ACTA NEUROPATHOLOGICA, 1988, 76 (05) :502-506
[3]  
BARTLETT GR, 1959, J BIOL CHEM, V234, P466
[4]  
BETBEDER D, 1996, Patent No. 21329
[5]  
D'amour FE, 1941, J PHARMACOL EXP THER, V72, P74
[6]   COLORIMETRIC METHOD FOR DETERMINATION OF SUGARS AND RELATED SUBSTANCES [J].
DUBOIS, M ;
GILLES, KA ;
HAMILTON, JK ;
REBERS, PA ;
SMITH, F .
ANALYTICAL CHEMISTRY, 1956, 28 (03) :350-356
[7]   THE EFFECTS OF PERMEATION ENHANCERS ON THE SURFACE-MORPHOLOGY OF THE RAT NASAL-MUCOSA - A SCANNING ELECTRON-MICROSCOPY STUDY [J].
ENNIS, RD ;
BORDEN, L ;
LEE, WA .
PHARMACEUTICAL RESEARCH, 1990, 7 (05) :468-475
[8]   THE RELEVANCE OF NASAL PHYSIOLOGY TO THE DESIGN OF DRUG ABSORPTION STUDIES [J].
GIZURARSON, S .
ADVANCED DRUG DELIVERY REVIEWS, 1993, 11 (03) :329-347
[9]   Uptake of inorganic mercury in the olfactory bulbs via olfactory pathways in rats [J].
Henriksson, J ;
Tjälve, H .
ENVIRONMENTAL RESEARCH, 1998, 77 (02) :130-140
[10]  
HOSOYA K, 1994, BIOL PHARM BULL, V17, P316